Tumor blood flow modifying effect of electrochemotherapy with bleomycin

Anticancer Research

Volumn 19, Issue 5 B, 1999, Pages 4017-4022

  Serša, Gregor ^a   Čemažar, Maja ^a   Miklavčič, Damijan ^b   Chaplin, David J ^c  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Bleomycin; Electrochemotherapy; Electroporation; Tumor blood flow

Indexed keywords

BLEOMYCIN; DISULFINE BLUE; RUBIDIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFICACY; ELECTROCHEMOTHERAPY; FEMALE; FIBROSARCOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR BLOOD FLOW; TUMOR NECROSIS;

EID: 0344719191     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Mir LM, Orlowski S, Belehradek JrJ, Teissie J, Rols MP, Sersa G, Miklavcic D, Gilbert R, Heller R: Biomedical application of electric pulses with special emphasis on antitumor electrochemotherapy. Bioelectroch Bioener 38: 203-207, 1945.
2. Orlowski S, Mir LM: Cell electropermeabilization: a new tool for biochemical and pharmacological studies. Biochim Biophys Acta 1154: 51-63, 1993.
3. Neumann E, Kakorin S: Digression on membrane electroporation and electroporative delivery of drugs and genes. Radiol Oncol 32: 7-17, 1998.
4. Heller R, Jaroszeski MJ, Atkin D, Moradpour R, Gilbert R, Wands J, Nicolau C: In vivo gene electroinjection and expression in rat liver. FEBS Lett 389: 225-228, 1996.
5. Veranic P, Jezernik K, Cemazar M, Sersa G: In vivo electroporation of the urinary bladder in mice. Radiol Oncol 32: 187-191, 1998.
6. Mir LM, Orlowski S, Belehradek JrJ, Paoletti C: Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer 27: 68-72, 1991.
7. Sersa G, Cemazar M, Miklavcic D: Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. Cancer Res 55: 3450-3455, 1995
8. Heller R, Jaroszeski MJ, Perrot R, Messina JL, Gilbert RA: Effective treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy. Melanoma Res 7: 10-18, 1997.
9. Pendas S, Jaroszeski MJ, Gilbert R, Hyacinthe M, Dang V, Hickey J, Pottinger C, Illingworth P, Heller R: Direct delivery of chemotherapeutic agents for the treatment of hepatomas and sarcomas in rat models. Radiol Oncol 32: 53-64, 1998.
10. Domenge C, Orlowski S, Luboinski B, De Baere T, Schwaab G, Belehradek JrJ Mir LM: Antitumor electrochemotherapy. New advances in the clinical protocol. Cancer 77: 956-963, 1996.
11. Heller R, Jaroszeski MJ, Glass LF, Messina JL, Rapaport DP, DeConti RC, Fenske NA, Gilbert RA, Mir LM, Reintgen DS: Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 77: 964-971, 1996.
12. Sersa G, Stabuc B, Cemazar M, Jancar B, Miklavcic D, Rudolf Z: Electrochemotherapy with cisplatin: Potentiation of local cisplatin antitumor effectiveness by application of electric pulses in cancer patients. Eur J Cancer 34: 1213-1218, 1998.
13. Mir LM, Glass L F, Sersa G, Teissie J, Domenge C, Miklavcic D, Jaroszeski MJ, Orlowski S, Reintgen DS, Rudolf Z, Belehradek M, Gilbert R, Rols MP, Belehradek JJr, Bauchard JM, DeConti R, αtabuc B, Cemazar M, Coninx P, Heller R: Effective treatment of cutaneous and subcutaneous malignant tumors by electrochemotherapy. Br J Cancer 77: 2336-2342, 1998.
14. Rudolf Z, Stabuc B, Cemazar M, Miklavcic D, Vodovnik L, Sersa G: Electrochemotherapy with bleomycin: The first clinical experience in malignant melanoma patients. Radiol Oncol 29: 229-235, 1995.
15. Sersa G, Stabuc B, Cemazar M, Miklavcic D, Rudolf Z: Electrochemotherapy with cisplatin: Clinical experience in malignant melanoma patients. Clin Cancer Res 1999, in press.
16. Panje WR, Hier MP, Garman GR, Harrell E, Goldman A, Bloch I: Electroporation therapy of head and neck cancer. Ann Otol Rhinol Laryngol 107: 779-785, 1998.
17. Sersa G, Cemazar M, Parkins CS, Chaplin DJ: Tumour blood flow changes induced by application of electric pulses. Eur J Cancer 35: 672-677, 1999.
18. Sersa G, Beravs K, Cemazar M, Miklavcic D, Demsar F: Contrast enhanced MRI assessment of tumor blood volume after application of electric pulses. Electro Magnetobiol 17: 299-306, 1998.
19. Cemazar M, Miklavcic D, Scancar J, Dolzan V, Golouh R, Sersa G: Increased platinum accumulation in SA-1 tumour cells after in vivo electrochemotherapy with cisplatin. Br J Cancer 79: 1386-1391, 1999.
20. Cemazar M, Milacic R, Miklavcic D, Dolzan V, Sersa G: Intratumoral cisplatin administration in electrochemotherapy: antitumor effectiveness, sequence dependence and platinum content. Anti-Cancer Drugs 9: 525-530, 1998.
21. Sersa G, Cemazar M, Miklavcic D: Changing electrode orientation improves the efficacy of electrochemotherapy of solid tumors in mice. Bioelectroch Bioener 39: 61-66, 1996.
22. Miklavcic D, Beravs K, Semrov D, Cemazar M, Demsar F, Sersa G: The importance of electric field distribution for effective in vivo electroporation of tissues. Biophys J 74: 2152-2158, 1998.
23. Semrov D, Miklavcic D: Calculation of the electrical parameters in electrochemotherapy of solid tumors in mice. Comput Biol Med 28: 439-448, 1998.
24. Sapirstein LA: Regional blood flow by fractional distribution of indicators. Am J Physiol 193: 161-168, 1958.
25. Hill SA, Denekamp J: Site dependent response of tumours to combined heat and radiation. Br J Radiol 55: 905-912, 1982.
26. Miklavcic D, Jarm T, Cemazar M, Sersa G, An DJ, Belehradek JrJ, Mir LM: Tumor treatment by direct electric current. Tumor perfusion changes. Bioelectroch Bioenerg 43: 253-256, 1997.
27. Chaplin DJ, Hill SA, Bell KM, Tozer GM: Modification of tumor blood flow: Current status and future direction. Sem Radiat Oncol 8: 151-163, 1998.
28. Denekamp J, Hill SA, Hobson B: Vascular occlusion and tumour cell death. Eur J Cancer Clin Oncol 19: 271-275, 1983.
29. Mir LM, Roth C, Orlowski S, Quintin-Colona F, Fradelizi D, Belehradek JJr, Kourilsky P: Systemic antitumor effect of electrochemotherapy combined with histoincompatible cells secreting interleukin-2. J Immunother 17: 30-8, 1995.
30. Sersa G, Miklavcic D, Cemazar M, Belehradek JJr, Jarm T, Mir LM: Electrochemotherapy with CDDP on LPB sarcoma: comparison of the antitumor effectiveness in immunocompetent and immunodeficient mice. Bioelectroch Bioenerg 43: 279-283, 1997.